Obliterative bronchiolitis following lung transplantation: from old to new concepts?
- 1 August 2009
- journal article
- review article
- Published by Frontiers Media SA in Transplant International
- Vol. 22 (8), 771-779
- https://doi.org/10.1111/j.1432-2277.2009.00872.x
Abstract
Lung transplantation has come of age and is now considered a valid treatment for selected patients with end-stage lung disease. In recent years, survival rates have much improved, although the development of chronic rejection, characterized by a progressive and irreversible decline in FEV(1), which is clinically defined as bronchiolitis obliterans syndrome (BOS) remains the major obstacle to long-term survival. Extensive research efforts with special emphasis on innate immunity have recently led to new insights with the identification of at least two different phenotypes: on the one hand there is an azithromycin-responsive phenotype (the so-called neutrophilic reversible allograft/airways dysfunction (NRAD), on the other hand there is an azithromycin-unresponsive phenotype (the fibroproliferative form of BOS or classical obliterative bronchiolitis). The present review intends to give the scientific evidence for these two subtypes, and to clarify the role of azithromycin in the treatment of BOS.Keywords
This publication has 62 references indexed in Scilit:
- Airway Colonization and Gastric Aspiration After Lung Transplantation: Do Birds of a Feather Flock Together?The Journal of Heart and Lung Transplantation, 2008
- Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?European Respiratory Journal, 2008
- IL-17–dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplantsJCI Insight, 2007
- Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allograftsThorax, 2007
- 222: Effect of azithromycin on gastroesophageal reflux (acid-non acid) and pepsin in BALF of lung transplant patientsThe Journal of Heart and Lung Transplantation, 2007
- The role of interleukin-17 during acute rejection after lung transplantationEuropean Respiratory Journal, 2006
- Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allograftsThorax, 2005
- Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejectionThe Journal of Heart and Lung Transplantation, 2004
- Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?The Journal of Heart and Lung Transplantation, 2002
- Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantationThorax, 2000